Glofitamab is a bispecific CD20-directed CD3 T-cell engager approved under the brand name Columvi ® for the treatment of adults with R/R DLBCL, not otherwise specified or large B-cell lymphoma arising ...

Astegolimab is a fully human anti-ST2 monoclonal antibody designed to bind to the ST2 receptor and block the IL-33 signalling pathway.

Opioids administered or prescribed in 35.0 and 32.5% of U.S. visits in 2016, respectively, compared with 24.5 and 13.5% in 2022.

Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester.

Aldosterone suppression testing is suggested where screening results indicate an intermediate probability for lateralizing PA and patients wish to pursue eligibility for surgical therapy.

HealthDay News — There was an overall decrease in influenza vaccine uptake among US adults from 2020 to 2024, according to a study published online July 16 in PLOS Global Public Health.

HealthDay News — The US Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they ...

The single-arm, open-label DR-OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who ...

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

In 2022, the FDA had made the decision to ban the products because the applications lacked sufficient evidence to show they met a public health standard.

While officials pointed to the department’s $1.8 trillion budget as a reason for the cuts, experts said payroll represented less than 1% of that amount.

The amended dosing regimen was approved based on results from a post hoc analysis of the phase 2 MagnetisMM-3 trial.